The notices it replaced
Its page names no earlier notice: it is new, or it does not say.
Replaced by PAR-25-311.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,928,930 in first-year total cost, median $1,669,596.
Most frequent study sections
- Special Emphasis Panel[ZHD1 DSR-C (55)]5
Most frequent institutions
- GEORGE WASHINGTON UNIVERSITY3
- RESEARCH TRIANGLE INSTITUTE2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Gestational hypertension and preeclampsia blood pressure (BP) Treatment goals <140/90 vs. <160/110 mmHg: The GOALPOST Trial1U01HD114633-01A1 | CLIFTON, REBECCA GERSNOVIEZGRIFFIN, LAURIE BETHROUSE, DWIGHT JSINKEY, RACHEL GTITA, ALAN THEVENET N. | GEORGE WASHINGTON UNIVERSITY, DC | $2,011,151 | ZHD1 |
| 2025 | Optimal Dosing of Understudied Drugs Administered to Pregnant Individuals per Standard of Care (PregDose)1U01HD118959-01 | CLIFTON, REBECCA GERSNOVIEZMETZ, TORRI DWATT, KEVIN M | GEORGE WASHINGTON UNIVERSITY, DC | $1,669,596 | ZHD1 |
| 2025 | Continued Pressure for Alveolar Protection: A Randomized Controlled Trial (CPAP Trial)1U01HD115553-01A1 | CARLO FONT, WALDEMAR A.DAS, ABHIK | RESEARCH TRIANGLE INSTITUTE, NC | $805,722 | ZHD1 |
| 2024 | Adjunctive Azithromycin Prophylaxis for Scheduled/Prelabor Cesarean Delivery1U01HD114634-01 | BOGGESS, KIM ACLIFTON, REBECCA GERSNOVIEZTITA, ALAN THEVENET N. | GEORGE WASHINGTON UNIVERSITY, DC | $3,614,140 | ZHD1 |
| 2024 | A Prospective Randomized Controlled Trial to Evaluate the Impact of Treatment of Asymptomatic Bacteriuria on Low Birth Weight1U01HD115569-01 | CHISHOLM, CHRISTIAN AMCCLURE, ELIZABETH M | RESEARCH TRIANGLE INSTITUTE, NC | $828,321 | ZHD1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.